The estimated Net Worth of Vance B. Moore is at least $3.17 Milione dollars as of 10 February 2022. Mr. Moore owns over 25,951 units of Omnicell stock worth over $2,895,079 and over the last 12 years he sold OMCL stock worth over $0. In addition, he makes $269,984 as Independent Director at Omnicell.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Moore OMCL stock SEC Form 4 insiders trading
Vance has made over 1 trades of the Omnicell stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 25,951 units of OMCL stock worth $1,117,710 on 10 February 2022.
The largest trade he's ever made was exercising 25,951 units of Omnicell stock on 10 February 2022 worth over $1,117,710. On average, Vance trades about 1,996 units every 0 days since 2012. As of 10 February 2022 he still owns at least 67,218 units of Omnicell stock.
You can see the complete history of Mr. Moore stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Vance Moore biography
Vance B. Moore is an Independent Director of Omnicell Inc. Since February 2016, Mr. Moore has served as a director of Omnicell since May 2012. Since February 2016, Mr. Moore has served as President, Business Integration of Mercy Health, a national healthcare system. From April 2011 to February 2016, Mr. Moore served as Senior Vice President, Operations of Mercy Health. From July 2006 to April 2011, Mr. Moore served as the President and Chief Executive Officer of Resource Optimization & Innovation (ROi), the supply chain operating division of Mercy Health. From August 1998 to March 2007, Mr. Moore served in various capacities at ROi, including Chief Operating Officer. From March 1999 to March 2002, Mr. Moore served as the Vice President, Sales and Marketing of the Healthcare Services Division of UPS Logistics Group, a global supply chain management services company. Mr. Moore also served as chairman of the board of ROi until its sale in October 2019 and a director of Ascension Ventures, a strategic healthcare venture fund, until his resignation in February 2020, and serves as a governing committee member of the Coordinating Center for the National Evaluation System for health Technology, a voluntary network of data partners focused on medical device performance. Mr. Moore received a B.S. in industrial management from the University of Arkansas.
What is the salary of Vance Moore?
As the Independent Director of Omnicell, the total compensation of Vance Moore at Omnicell is $269,984. There are 15 executives at Omnicell getting paid more, with Randall Lipps having the highest compensation of $7,208,970.
How old is Vance Moore?
Vance Moore is 59, he's been the Independent Director of Omnicell since 2012. There are 11 older and 7 younger executives at Omnicell. The oldest executive at Omnicell, Inc. is Sara White, 74, who is the Independent Director.
What's Vance Moore's mailing address?
Vance's mailing address filed with the SEC is OMNICELL, INC, 4220 NORTH FREEWAY, FORT WORTH, TX, 76137.
Insiders trading at Omnicell
Over the last 21 years, insiders at Omnicell have traded over $118,258,750 worth of Omnicell stock and bought 526,030 units worth $5,215,749 . The most active insiders traders include William H Jr Younger, Randall A Lipps e Benjamin A Horowitz. On average, Omnicell executives and independent directors trade stock every 10 days with the average trade being worth of $482,255. The most recent stock trade was executed by Christine Marie Mellon on 9 June 2023, trading 7,951 units of OMCL stock currently worth $581,536.
What does Omnicell do?
since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice
What does Omnicell's logo look like?
Complete history of Mr. Moore stock trades at Omnicell
Omnicell executives and stock owners
Omnicell executives and other stock owners filed with the SEC include:
-
Randall Lipps,
Chairman of the Board, President, Chief Executive Officer -
Peter Kuipers,
Chief Financial Officer, Executive Vice President -
Scott Seidelmann,
Executive Vice President and Chief Commercial Officer -
Randall A. Lipps,
Founder, Exec. Chairman, Pres & CEO -
Nhat Ngo,
Executive Vice President - Marketing, Strategy and Business Development -
Daniel Johnston,
Executive Vice President, Chief Legal and Administrative Officer -
Peter J. Kuipers,
Exec. VP & CFO -
Scott Peter Seidelmann,
Exec. VP & Chief Commercial Officer -
Christine Mellon,
Exec. VP, Chief Admin. & People Officer -
Robin Seim,
Director -
Bruce Scott,
Independent Director -
James Judson,
Lead Independent Director -
Joanne Bauer,
Independent Director -
Mark Parrish,
Independent Director -
Sara White,
Independent Director -
Vance Moore,
Independent Director -
Bruce Smith,
Independent Director -
Joseph Spears,
Senior Vice President, Chief Accounting Officer, Corporate Controller -
Jorge R. Taborga,
Exec. VP of Engineering & Integration Management Officer -
Roxanne Turner,
VP of Corp. Responsibility & Chief Compliance Officer -
Corey J. Manley,
Sr. VP & Chief Legal Officer -
Kathleen Nemeth,
Sr. VP of Investor Relations -
Giri Chodavarapu,
Sr. VP & Chief Information Officer -
Joseph Brian Spears,
Sr. VP, Chief Accounting Officer & Corp. Controller -
Gary S Petersmeyer,
Director -
Jorge R. Taborga,
Executive VP. Engineering -
J Christopher Drew,
EVP, Business Development -
Randy D Lindholm,
Director -
Corey J Manley,
EVP&CHIEF LEGAL/ADMIN OFFICER -
Nchacha Etta,
EVP & CFO -
Kaushik Ghoshal,
-
Marga Ortigas Wedekind,
Vice President, Marketing -
Donald C Wegmiller,
Director -
Mary E Foley,
Director -
William G. Shields,
Executive Vice President -
Michael D Stevenson,
Exec. VP, Global Manufacturing -
Joseph E Whitters,
Director -
William H Jr Younger,
Director -
Partners Iii Llc Abs,
10% owner -
Renee M Luhr,
VP Sales -
Brock Nelson,
Director -
Brian Robert Rodli,
Vice President/Marketing -
Charles J Barnett,
Director -
Benjamin A Horowitz,
Director -
Timothy T Weglicki,
10% owner -
John D Jr Stobo,
Director -
Capital Partners Iii L P Abs,
10% owner -
John D Higham,
SVP Marketing -
Kevin L Roberg,
Director -
John Choma,
S.V.P. H.R. Emp. Learn & Perf. -
Dennis P Wolf,
Exec VP, CFO -
Gary E Wright,
Exec VP Sales -
Donald B Jr Hebb,
10% owner -
Chusak Siripocanont,
Sr. VP, Eng., Mfg. & Quality -
Edward Peter Bousa,
-
Eileen J. Voynick,
-
Mary Garrett,
-
Dan S Johnston,
EVP, EXECUTIVE ADVISOR -
Christine Marie Mellon,
EVP, EXECUTIVE ADVISOR -
Brian H. Nutt,
VP, Chief Accounting Officer